Instil Bio, Inc. (TIL)

USD 19.6

(-9.64%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - 138 Thousand -
Cost of Revenue 4.75 Million 5.98 Million 2.75 Million - 20 Thousand
Gross Profit -4.75 Million -5.98 Million -2.75 Million 138 Thousand -20 Thousand
Operating Expenses 85.78 Million 203.29 Million 155.56 Million 33.78 Million 6.58 Million
Selling, General and Administrative Expenses 47.55 Million 62.23 Million 48.3 Million 14.38 Million 2.55 Million
Research and Development Expenses 42.98 Million 141.05 Million 107.25 Million 19.39 Million 4.02 Million
Other Expenses 72.01 Million -564 Thousand -1.19 Million -4.65 Million -5000.00
Cost and Expenses 90.54 Million 203.29 Million 155.56 Million 33.78 Million 6.58 Million
Operating Income -159.16 Million -226.45 Million -155.56 Million -33.64 Million -6.58 Million
Interest Expense 5.2 Million 1.88 Million - - -
Income Tax Expense - -2.07 Million 39 Thousand 151 Thousand -68 Thousand
Earnings before Tax -156.08 Million -225.25 Million -156.75 Million -37.58 Million -6.52 Million
Net Income -156.08 Million -223.17 Million -156.79 Million -37.73 Million -6.45 Million
Earnings Per Share Basic -24.00 -34.46 -24.30 -5.89 -1.01
Earnings Per Share Diluted -24.00 -34.46 -24.30 -5.89 -1.01
Weighted Average Shares Outstanding 6.5 Million 6.47 Million 6.45 Million 6.41 Million 6.41 Million
Weighted Average Shares Outstanding (Diluted) 6.5 Million 6.47 Million 6.45 Million 6.41 Million 6.41 Million
Gross Margin - - - 1.00 -
EBIT Margin - - - -246.60 -
Profit Margin - - - -273.46 -
EBITDA -146.12 Million -217.38 Million -154 Million -33.38 Million -6.5 Million
Earnings Before Tax Margin - - - -243.80 -

Income Statement Charts